Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP), 9523 [2019-04823]

Download as PDF Federal Register / Vol. 84, No. 51 / Friday, March 15, 2019 / Notices patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—GH19–013, Advancing Infectious Disease Detection and Response in Liberia. Date: April 30, 2019. Time: 9:00 a.m.–2:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Drive, Atlanta, GA 30329–4027, (404) 639– 4796; HShoob@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–04825 Filed 3–14–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public, limited only by the space available. The meeting room will accommodate up to 60 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports available (100). Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is Monday, April 15, 2019. Persons who desire to make an amozie on DSK9F9SC42PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:53 Mar 14, 2019 Jkt 247001 oral statement, may request it at the time of the public comment period on April 16, 2019 at 3:20 p.m. EDT. The meeting will be held on April 16, 2019, 10:00 a.m. to 3:30 p.m., EDT. DATES: 8 Corporate Blvd., Building 8, Conference Rooms 1A and 1B, Atlanta, Georgia 30329 and Web conference: 1–877–927–1433 and participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l 2tytpq/. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E–07, Atlanta, Georgia 30329–4018, telephone (404) 639–8317; zkr7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to be considered: The agenda will include discussions on (1) Overview of the ‘‘Digital Bridge’’; (2) Overview of tuberculosis care for migrant detainees; (3) Overview of infrastructure and mechanisms to develop, update, and maintain HIV guidelines; and (4) Update from ACET workgroups. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–04822 Filed 3–14–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 9523 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) CK19–002, Quantifying Contact Rates and Mixing Patterns in Workers in NonHealthcare Work Settings in the United States and CK19–004, Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD). Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); CK19– 002, Quantifying Contact Rates and Mixing Patterns in Workers in NonHealthcare Work Settings in the United States and CK19–004, Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD); May 7, 2019; 10:00 a.m.– 5:00 p.m., (EDT) which was published in the Federal Register on December 26, 2018, Volume 83, Number 246, pages 66270. The meeting is being amended to add CK17–005SUPP, Vector-Borne Disease Regional Centers of Excellence. The meeting is closed to the public. Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30333, (404) 718–8833, gca5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–04823 Filed 3–14–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 84, Number 51 (Friday, March 15, 2019)]
[Notices]
[Page 9523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04823]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)

    CK19-002, Quantifying Contact Rates and Mixing Patterns in Workers 
in Non-Healthcare Work Settings in the United States and CK19-004, 
Study to Assess the Risk of Blood Borne Transmission of Classic Forms 
of Creutzfeldt-Jakob Disease (CJD).

Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP); CK19-002, Quantifying Contact Rates and Mixing Patterns in 
Workers in Non-Healthcare Work Settings in the United States and CK19-
004, Study to Assess the Risk of Blood Borne Transmission of Classic 
Forms of Creutzfeldt-Jakob Disease (CJD); May 7, 2019; 10:00 a.m.-5:00 
p.m., (EDT) which was published in the Federal Register on December 26, 
2018, Volume 83, Number 246, pages 66270.
    The meeting is being amended to add CK17-005SUPP, Vector-Borne 
Disease Regional Centers of Excellence. The meeting is closed to the 
public.
    Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, 
CDC, 1600 Clifton Road NE, Mailstop E60, Atlanta, Georgia 30333, (404) 
718-8833, gca5@cdc.gov.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-04823 Filed 3-14-19; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.